Procedure
Portal vein embolization
Portal vein embolization is a medical procedure with 6 clinical trials. Currently 2 active trials ongoing. Historical success rate of 66.7%.
Total Trials
6
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
2(33%)
Results Posted
0%(0 trials)
Terminated
1(17%)
Phase Distribution
Ph phase_2
1
17%
Ph not_applicable
3
50%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
2
trials recruiting
Total Trials
6
all time
Status Distribution
Active(2)
Completed(2)
Terminated(1)
Other(1)
Detailed Status
Completed2
Recruiting2
Terminated1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
2
Success Rate
66.7%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (25.0%)
N/A3 (75.0%)
Trials by Status
terminated117%
completed233%
unknown117%
recruiting233%
Recent Activity
2 active trials
Showing 5 of 6
recruitingnot_applicable
Hepatic and Systemic Hemodynamic Modeling During Liver Surgery
NCT05339984
recruitingnot_applicable
The Dragon PLC Trial (DRAGON-PLC)
NCT06914648
completed
Comparison of N-butyl-cyanoacrylate and Micro Parti-cles Effect in Inducing Liver Hypertrophy After PVE
NCT05660759
unknown
Scandinavian Cohort Study for Optimal Use of Portal Vein Embolization
NCT04182386
completedphase_2
Cd133+ Cell Infusion in Patients With Colorectal Liver Metastases.
NCT03803241
Clinical Trials (6)
Showing 6 of 6 trials
NCT05339984Not Applicable
Hepatic and Systemic Hemodynamic Modeling During Liver Surgery
NCT06914648Not Applicable
The Dragon PLC Trial (DRAGON-PLC)
NCT05660759
Comparison of N-butyl-cyanoacrylate and Micro Parti-cles Effect in Inducing Liver Hypertrophy After PVE
NCT04182386
Scandinavian Cohort Study for Optimal Use of Portal Vein Embolization
NCT03803241Phase 2
Cd133+ Cell Infusion in Patients With Colorectal Liver Metastases.
NCT02618447Not Applicable
4D Phase Contrast MR: Hypertrophy in Liver Cancer
All 6 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 6